NasdaqGS - Nasdaq Real Time Price USD
Metagenomi, Inc. (MGX)
1.7100
+0.0500
+(3.01%)
As of 9:48:51 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-102,065
-109,073
-91,409
29,724
24,257
Investing Cash Flow
31,303
-88,157
45,734
-122,200
-74,316
Financing Cash Flow
-2,601
84,013
1,012
239,594
39,922
End Cash Position
34,443
32,634
145,851
190,514
43,396
Income Tax Paid Supplemental Data
--
3,505
2,250
0
--
Capital Expenditure
-2,487
-3,114
-9,814
-13,977
-2,903
Issuance of Capital Stock
-2,524
84,013
4,295
239,594
9,948
Issuance of Debt
--
--
--
0
29,974
Free Cash Flow
-104,552
-112,187
-101,223
15,747
21,354
12/31/2021 - 2/9/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GPCR Structure Therapeutics Inc.
21.84
+1.72%
KYTX Kyverna Therapeutics, Inc.
3.1100
+5.78%
PRME Prime Medicine, Inc.
1.6250
+19.49%
TNYA Tenaya Therapeutics, Inc.
0.5669
+4.97%
STRO Sutro Biopharma, Inc.
0.8603
+4.37%
ELEV Elevation Oncology, Inc.
0.3050
-0.03%
ZURA Zura Bio Limited
1.2000
+4.31%
DTIL Precision BioSciences, Inc.
5.33
+3.93%
ANRO Alto Neuroscience, Inc.
2.4800
+4.42%
GBIO Generation Bio Co.
0.3732
+2.08%